China Pharma Holdings, Inc. (CPHI) is a publicly traded Healthcare sector company. As of November 18, 2026, CPHI trades at $0.50 with a market cap of $20.65M and a P/E ratio of -1.57. CPHI moved +5.21% today. Year to date, CPHI is -59.17%; over the trailing twelve months it is -66.93%. Its 52-week range spans $0.38 to $19.19. Rallies surfaces CPHI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
China Pharma delays third-quarter report, targets Nov. 23 filing: China Pharma Holdings delayed its Form 10-Q for the quarter ended September 30, 2026, and is targeting a November 23 filing. Preliminary revenue was approximately $1.15 million, while operating and net losses were approximately $1.88 million and $1.9 million, respectively.
| Metric | Value |
|---|---|
| Price | $0.50 |
| Market Cap | $20.65M |
| P/E Ratio | -1.57 |
| EPS | $-0.42 |
| Dividend Yield | 0.00% |
| 52-Week High | $19.19 |
| 52-Week Low | $0.38 |
| Volume | 104.12K |
| Avg Volume | 0 |
| Revenue (TTM) | $3.91M |
| Net Income | $-4.47M |
| Gross Margin | 11.76% |
CPHI analyst coverage data. Average price target: $0.00.